PDK1 and hepatocellular carcinoma: As the previous study identified, CDK1 was overexpressed in hepatocellular carcinoma and was related to the development of tumor through the CDK1/PDK1/β-Catenin pathway, which could predict worse survival outcomes [56, 57].